Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.58 USD | -0.77% |
|
+7.05% | -43.91% |
Jun. 28 | NRx Pharmaceuticals, Inc. to Proceed with Two New Drug Applications in 2024 | CI |
Jun. 18 | NRx Pharmaceuticals, Inc. Appoints Dennis McBride to Its Board of Directors | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.91% | 27.67M | |
+16.59% | 44.44B | |
+41.02% | 39.84B | |
-10.62% | 37.68B | |
+29.92% | 31.46B | |
-9.23% | 27.02B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |
- Stock Market
- Equities
- BRPA Stock
- News NRx Pharmaceuticals, Inc.
- NRx Pharmaceuticals Looking to Sell Shares to Fund General Corporate Activities; Shares Slump Premarket